Ascendis Pharma A/S Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 10.28 M | $2.74 B | 100.00% | 15.98% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 6.75 M | $1.80 B | 9.62% | 10.50% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 5.11 M | $1.36 B | 100.00% | 7.94% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 08/12/2026 | 4.80 M | $1.28 B | 100.00% | 7.46% |
| JUPITER TOPCO LLC | 08/14/2026 | 3.65 M | $973.38 M | 100.00% | 5.67% |
| FMR LLC | 08/13/2026 | 3.55 M | $945.68 M | 100.00% | 5.51% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/13/2026 | 2.63 M | $702.55 M | 100.00% | 4.09% |
| BLACKROCK, INC. | 08/07/2026 | 2.21 M | $589.94 M | 100.00% | 3.44% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 1.99 M | $530.40 M | 100.00% | 3.09% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 08/03/2026 | 1.88 M | $500.14 M | 100.00% | 2.91% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.86 M | $496.77 M | 100.00% | 2.89% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 1.55 M | $413.05 M | 100.00% | 2.41% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 1.40 M | $373.56 M | 100.00% | 2.18% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 1.16 M | $310.39 M | 100.00% | 1.81% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.12 M | $299.40 M | -26.65% | 1.74% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 906.08 K | $241.67 M | 100.00% | 1.41% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 873.50 K | $232.98 M | 100.00% | 1.36% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 616.91 K | $164.54 M | 100.00% | 0.96% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 559.53 K | $149.24 M | 100.00% | 0.87% |
| MORGAN STANLEY | 08/13/2026 | 544.39 K | $145.20 M | 100.00% | 0.85% |
| STATE STREET CORP | 09/22/2026 | 513.97 K | $137.09 M | 100.00% | 0.83% |
| INVESCO LTD. | 08/14/2026 | 414.20 K | $110.47 M | 100.00% | 0.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 403.15 K | $107.53 M | 100.00% | 0.63% |
| UBS GROUP AG | 08/13/2026 | 401.88 K | $107.19 M | 100.00% | 0.62% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 399.29 K | $106.50 M | 100.00% | 0.62% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 375.00 K | $100.02 M | 100.00% | 0.58% |
| JPMORGAN CHASE & CO | 08/12/2026 | 367.78 K | $96.98 M | 100.00% | 0.57% |
| FIL LTD | 08/13/2026 | 345.57 K | $92.17 M | 100.00% | 0.54% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 320.51 K | $85.49 M | 100.00% | 0.50% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 319.41 K | $85.19 M | 100.00% | 0.50% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 305.80 K | $81.56 M | 100.00% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 266.71 K | $71.14 M | 100.00% | 0.41% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 260.64 K | $69.52 M | 100.00% | 0.41% |
| TRI LOCUM PARTNERS LP | 08/14/2026 | 258.74 K | $69.01 M | 100.00% | 0.40% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 244.46 K | $65.20 M | 100.00% | 0.38% |
| SEI INVESTMENTS CO | 08/14/2026 | 237.87 K | $63.44 M | 100.00% | 0.37% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 225.16 K | $60.05 M | 68.87% | 0.37% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 234.04 K | $62.27 M | 100.00% | 0.36% |
| PFM HEALTH SCIENCES, LP | 08/14/2026 | 233.17 K | $62.19 M | 100.00% | 0.36% |
| SPYGLASS CAPITAL MANAGEMENT LLC | 08/14/2026 | 215.40 K | $57.45 M | 100.00% | 0.33% |
| ARS INVESTMENT PARTNERS, LLC | 07/09/2026 | 210.46 K | $56.13 M | 100.00% | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 206.23 K | $55.01 M | 100.00% | 0.32% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/29/2026 | 191.79 K | $51.15 M | 100.00% | 0.30% |
| EMPOWERED FUNDS, LLC | 08/17/2026 | 187.27 K | $49.95 M | 100.00% | 0.29% |
| JANE STREET GROUP, LLC | 08/14/2026 | 187.14 K | $49.91 M | 100.00% | 0.29% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 08/13/2026 | 178.74 K | $47.86 M | 100.00% | 0.28% |
| CITADEL ADVISORS LLC | 09/02/2026 | 175.80 K | $46.89 M | 100.00% | 0.27% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 173.45 K | $46.26 M | 100.00% | 0.27% |
| FRED ALGER MANAGEMENT, LLC | 08/14/2026 | 171.45 K | $45.73 M | 100.00% | 0.27% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 168.75 K | $45.01 M | 100.00% | 0.26% |
Ascendis Pharma A/S institutional Ownership - FAQ's
During the previous two years, 422 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:
SAPIENT CAPITAL LLC: 95,721
TOTH FINANCIAL ADVISORY CORP: 4,830
GAMMA Investing LLC: 1,581
Farther Finance Advisors, LLC: 609
Bank of New Hampshire: 72
Roxbury Financial LLC: 42
104.00% of Ascendis Pharma A/S stock is owned by institutional investors.
Institutional investors have bought a total of 70.80 M shares in the last 24 months. This purchase volume represents approximately $16.99 B in transactions.